Logo image of MCHX

MARCHEX INC-CLASS B (MCHX) Stock Fundamental Analysis

NASDAQ:MCHX - Nasdaq - US56624R1086 - Common Stock - Currency: USD

2.0274  0 (-0.13%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MCHX. MCHX was compared to 98 industry peers in the Media industry. No worries on liquidiy or solvency for MCHX as it has an excellent financial health rating, but there are worries on the profitability. MCHX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MCHX has reported negative net income.
In the past year MCHX has reported a negative cash flow from operations.
In the past 5 years MCHX always reported negative net income.
In the past 5 years MCHX always reported negative operating cash flow.
MCHX Yearly Net Income VS EBIT VS OCF VS FCFMCHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

MCHX has a Return On Assets of -13.48%. This is in the lower half of the industry: MCHX underperforms 73.47% of its industry peers.
MCHX's Return On Equity of -17.46% is on the low side compared to the rest of the industry. MCHX is outperformed by 60.20% of its industry peers.
Industry RankSector Rank
ROA -13.48%
ROE -17.46%
ROIC N/A
ROA(3y)-15.59%
ROA(5y)-20.68%
ROE(3y)-20.46%
ROE(5y)-28.56%
ROIC(3y)N/A
ROIC(5y)N/A
MCHX Yearly ROA, ROE, ROICMCHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 64.66%, MCHX is in the better half of the industry, outperforming 77.55% of the companies in the same industry.
In the last couple of years the Gross Margin of MCHX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for MCHX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y-1.35%
MCHX Yearly Profit, Operating, Gross MarginsMCHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

7

2. Health

2.1 Basic Checks

MCHX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MCHX has been increased compared to 1 year ago.
Compared to 5 years ago, MCHX has less shares outstanding
There is no outstanding debt for MCHX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MCHX Yearly Shares OutstandingMCHX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MCHX Yearly Total Debt VS Total AssetsMCHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

MCHX has an Altman-Z score of -4.40. This is a bad value and indicates that MCHX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -4.40, MCHX is not doing good in the industry: 82.65% of the companies in the same industry are doing better.
MCHX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.4
ROIC/WACCN/A
WACC9.16%
MCHX Yearly LT Debt VS Equity VS FCFMCHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.50 indicates that MCHX has no problem at all paying its short term obligations.
MCHX has a Current ratio of 2.50. This is amongst the best in the industry. MCHX outperforms 84.69% of its industry peers.
MCHX has a Quick Ratio of 2.50. This indicates that MCHX is financially healthy and has no problem in meeting its short term obligations.
MCHX has a Quick ratio of 2.50. This is amongst the best in the industry. MCHX outperforms 84.69% of its industry peers.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 2.5
MCHX Yearly Current Assets VS Current LiabilitesMCHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

MCHX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -66.67%.
The Revenue has decreased by -2.67% in the past year.
The Revenue has been decreasing by -2.46% on average over the past years.
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y-3.47%
Revenue growth 5Y-2.46%
Sales Q2Q%-1.48%

3.2 Future

MCHX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.10% yearly.
MCHX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.22% yearly.
EPS Next Y23.5%
EPS Next 2Y32.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.5%
Revenue Next 2Y1.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCHX Yearly Revenue VS EstimatesMCHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MCHX Yearly EPS VS EstimatesMCHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.1 -0.1 0.2 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MCHX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MCHX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MCHX Price Earnings VS Forward Price EarningsMCHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MCHX Per share dataMCHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

A more expensive valuation may be justified as MCHX's earnings are expected to grow with 32.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.1%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MCHX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARCHEX INC-CLASS B

NASDAQ:MCHX (7/25/2025, 8:04:20 PM)

2.0274

0 (-0.13%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)07-31 2025-07-31
Inst Owners62.83%
Inst Owner Change0.93%
Ins Owners8.5%
Ins Owner Change0%
Market Cap89.00M
Analysts82.86
Price Target4.08 (101.24%)
Short Float %0.07%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-71.57%
Min EPS beat(2)-96.08%
Max EPS beat(2)-47.06%
EPS beat(4)0
Avg EPS beat(4)-67.48%
Min EPS beat(4)-96.08%
Max EPS beat(4)-30.72%
EPS beat(8)4
Avg EPS beat(8)-6.21%
EPS beat(12)6
Avg EPS beat(12)-16.73%
EPS beat(16)10
Avg EPS beat(16)4.05%
Revenue beat(2)0
Avg Revenue beat(2)-4.45%
Min Revenue beat(2)-6.22%
Max Revenue beat(2)-2.69%
Revenue beat(4)0
Avg Revenue beat(4)-3.41%
Min Revenue beat(4)-6.22%
Max Revenue beat(4)-2.27%
Revenue beat(8)0
Avg Revenue beat(8)-3.36%
Revenue beat(12)0
Avg Revenue beat(12)-3.41%
Revenue beat(16)2
Avg Revenue beat(16)-2.57%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-50%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)0.67%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)1.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.86
P/FCF N/A
P/OCF N/A
P/B 2.84
P/tB 6.44
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS1.09
BVpS0.71
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.48%
ROE -17.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.66%
FCFM N/A
ROA(3y)-15.59%
ROA(5y)-20.68%
ROE(3y)-20.46%
ROE(5y)-28.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y-1.35%
F-Score6
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.45%
Cap/Sales 1.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.5
Quick Ratio 2.5
Altman-Z -4.4
F-Score6
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)40.99%
Cap/Depr(5y)32.87%
Cap/Sales(3y)3.05%
Cap/Sales(5y)2.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y23.5%
EPS Next 2Y32.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y-3.47%
Revenue growth 5Y-2.46%
Sales Q2Q%-1.48%
Revenue Next Year3.5%
Revenue Next 2Y1.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y73.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.27%
OCF growth 3YN/A
OCF growth 5YN/A